Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report

A 57‐year‐old woman who was inoculated with the second dose of the mRNA‐1273 Moderna COVID‐19 vaccine and then developed adult‐onset still’s disease as a result.[Image: see text]

Detalles Bibliográficos
Autores principales: Iwata, Masahiro, Ogawa, Tatsuya, Anju, Keisuke, Okiyama, Naoko, Nomura, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874601/
http://dx.doi.org/10.1002/cia2.12281
_version_ 1784877815653466112
author Iwata, Masahiro
Ogawa, Tatsuya
Anju, Keisuke
Okiyama, Naoko
Nomura, Toshifumi
author_facet Iwata, Masahiro
Ogawa, Tatsuya
Anju, Keisuke
Okiyama, Naoko
Nomura, Toshifumi
author_sort Iwata, Masahiro
collection PubMed
description A 57‐year‐old woman who was inoculated with the second dose of the mRNA‐1273 Moderna COVID‐19 vaccine and then developed adult‐onset still’s disease as a result.[Image: see text]
format Online
Article
Text
id pubmed-9874601
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98746012023-01-25 Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report Iwata, Masahiro Ogawa, Tatsuya Anju, Keisuke Okiyama, Naoko Nomura, Toshifumi Journal of Cutaneous Immunology and Allergy Correspondence A 57‐year‐old woman who was inoculated with the second dose of the mRNA‐1273 Moderna COVID‐19 vaccine and then developed adult‐onset still’s disease as a result.[Image: see text] John Wiley and Sons Inc. 2022-10-19 /pmc/articles/PMC9874601/ http://dx.doi.org/10.1002/cia2.12281 Text en © 2022 The Authors. Journal of Cutaneous Immunology and Allergy published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society for Cutaneous Immunology and Allergy. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Correspondence
Iwata, Masahiro
Ogawa, Tatsuya
Anju, Keisuke
Okiyama, Naoko
Nomura, Toshifumi
Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
title Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
title_full Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
title_fullStr Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
title_full_unstemmed Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
title_short Adult‐onset Still's disease following mRNA‐1273 Moderna COVID‐19 vaccination: A case report
title_sort adult‐onset still's disease following mrna‐1273 moderna covid‐19 vaccination: a case report
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874601/
http://dx.doi.org/10.1002/cia2.12281
work_keys_str_mv AT iwatamasahiro adultonsetstillsdiseasefollowingmrna1273modernacovid19vaccinationacasereport
AT ogawatatsuya adultonsetstillsdiseasefollowingmrna1273modernacovid19vaccinationacasereport
AT anjukeisuke adultonsetstillsdiseasefollowingmrna1273modernacovid19vaccinationacasereport
AT okiyamanaoko adultonsetstillsdiseasefollowingmrna1273modernacovid19vaccinationacasereport
AT nomuratoshifumi adultonsetstillsdiseasefollowingmrna1273modernacovid19vaccinationacasereport

Ejemplares similares